Dr. Jonathan Myers| Clinical Trials|Best Researcher Award

Published on by Top Pharmaceutical

Dr.JonathanMyers|Clinical Trials|Best Researcher Award

Dr. Jonathan Myers at VA Palo Alto Health Care System,United States

PROFILE  

orcid

scopus

Summary 🎉

Dr. Jonathan Myers is a distinguished Clinical Professor of Medicine at Stanford University, celebrated for his extensive contributions to exercise physiology and cardiovascular health. With over four decades of experience in academia and clinical research, his work has significantly advanced the field, particularly in exercise testing and rehabilitation for patients with cardiovascular diseases.

Education 🎓

Dr. Myers began his academic journey with a Bachelor of Arts in Ergonomics and Physical Education from the University of California, Santa Barbara in 1980. He pursued a Master’s in Exercise Physiology at San Diego State University in 1982 and completed his PhD at the University of Southern California in 1991. His educational foundation has profoundly influenced his research and clinical practices.

Professional Experience 🏥

Dr. Myers has held various prestigious positions, including Clinical Professor at Stanford University since 2008. His role as a Research Career Scientist for the Veterans Administration since 2004 underscores his commitment to improving veterans’ lives through innovative rehabilitation strategies. He has also served as a Clinical Associate and Assistant Professor at Stanford and directed the Exercise Research Laboratory at the Long Beach Veterans Affairs Medical Center.

Contributions and Research Focus 🔬

Dr. Myers has made significant contributions to exercise physiology, particularly in cardiopulmonary exercise testing and cardiac rehabilitation. His research focuses on the physiological responses to exercise in various populations, including those with cardiovascular diseases, diabetes, and spinal cord injuries. He has played a key role in developing guidelines for exercise testing and prescription, influencing clinical practices globally.

Accolades and Recognition 🏆

Dr. Myers has received numerous awards, including the Citation Award from the American College of Sports Medicine (2021) and the Distinguished Professor Award from the Mexican Society of Cardiac Rehabilitation (2021). His accolades reflect his leadership and dedication to enhancing exercise science.

Impact and Influence 🌍

Dr. Myers’ influence extends beyond academia into public health and clinical practice. As a member of various organizations and committees, he has shaped policies advocating for the integration of exercise in healthcare. His involvement in the Healthy Living for Pandemic Event Protection (HL-PIVOT) Network emphasizes the importance of exercise in public health strategies.

Legacy and Future Contributions 🔮

Looking ahead, Dr. Myers aims to continue his research in exercise physiology, focusing on the needs of diverse populations, particularly in chronic diseases and rehabilitation. His dedication to mentorship and teaching will inspire the next generation of exercise physiologists. Dr. Myers remains committed to advocating for the critical role of physical activity in maintaining health and preventing disease, leaving a legacy of innovation and unwavering support for improving quality of life through exercise.

🎓Publication 

Impact of Cardiorespiratory Fitness on COVID-19–Related Outcomes: The Exercise Testing and Health Outcomes Study (ETHOS)

  • Authors   :Peter Kokkinos; Cristina Cadenas-Sanchez; Angelike Liappis; Carl J. Lavie; Navjit K. Goraya; Amy Weintrob; Andreas Pittaras; Alexandros Ladas
  • Journal    : Mayo Clinic Proceedings
  • Year         :2024

Analysis of Demographic and Socioeconomic Factors Influencing Adherence to a Web-Based Intervention Among Patients After Acute Coronary Syndrome: Prospective Observational Cohort Study (Preprint)

  • Authors   :Biagio Sassone; Giuseppe Fuca’; Mario Pedaci; Roberta Lugli; Enrico Bertagnin; Santo Virzi’; Manuela Bovina; Giovanni Pasanisi; Simona Mandini; Jonathan 
  • Journal    :Preprint
  • Year         :2024

 

Hypertension and Ventilatory Responses During Exercise in the Fitness Registry and the Importance of Exercise National Database (FRIEND)

  • Authors   :  Joseph C. Watso; Austin T. Robinson; Ross Arena; Matthew P. Harber; Leonard A. Kaminsky; Jonathan Myers
  • Journal    :The Journal of Infection in Developing Countries
  • Year         :2024

Analysis of Demographic and Socioeconomic Factors Influencing Adherence to a Web-Based Intervention Among Patients After Acute Coronary Syndrome: Prospective Observational Cohort Study

  • Authors   : Biagio Sassone; Giuseppe Fuca’; Mario Pedaci; Roberta Lugli; Enrico Bertagnin; Santo Virzi’; Manuela Bovina; Giovanni Pasanisi; Simona Mandini; Jonathan
  • Journal    :JMIR Cardio
  • Year         :2024

Dr. SEEMA KUMARI| MICROBIOLOGY|Best Researcher Award

Published on by Top Pharmaceutical

Dr. SEEMA KUMARI|MICROBIOLOGY|Best Researcher Award

Dr. SEEMA KUMARI at PANJAB UNIVERSITY,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Seema Kumari began her academic journey with a strong foundation in the biological sciences. She completed her B.Sc. in Medical Sciences in 2000 from Himachal Pradesh University, Shimla, setting the stage for a specialization in microbiology. Continuing her pursuit of knowledge, she earned her M.Sc. in Microbiology from the same university in 2002. Her passion for the field led her to pursue a Ph.D. in Microbiology from Panjab University, Chandigarh, which she successfully completed in 2010. Her academic credentials laid a solid groundwork for her future endeavors in both teaching and research.

Professional Endeavors 🧑‍🏫

Dr. Seema Kumari’s teaching career commenced soon after completing her Ph.D. She gained valuable experience in various educational institutions. She initially served as a Lecturer (Guest Faculty) at Baba Balak Nath College, Chakmoh, Himachal Pradesh, from 2002 to 2004. Later, she worked at Bhojia Institute of Life Sciences, Baddi, Solan, as a Lecturer on a contract basis from 2009 to 2010. In 2010, she took up a position at the Shoolini Institute of Life Sciences and Business Management, Solan, as a regular lecturer, which further honed her teaching expertise.

In 2011, Dr. Kumari joined Panjab University, Chandigarh, as an Assistant Professor in the Department of Microbiology. Since then, she has been a permanent faculty member, contributing to the growth of the department and the academic enrichment of her students. Her teaching style and research-driven approach have made her a valuable asset to the university.

Contributions and Research Focus 🔬

Dr. Kumari’s research primarily focuses on microbiology, particularly the role of bacteriophages in combating bacterial infections, a topic that has gained global attention due to the rise of antibiotic resistance. Her research delves into the use of bacteriophages and phytochemicals as agents to combat bacterial biofilms, which are often resistant to conventional antibiotics. Another key area of her work is the evaluation of biosurfactants’ antibacterial and anti-adhesive properties and their application in medical settings, specifically for treating infections caused by multi-drug-resistant bacteria.

Additionally, Dr. Kumari has been exploring the potential of medicinal plants and bacteriophages in anti-obesity treatments. Her innovative approach in integrating traditional knowledge with modern microbiological techniques has opened new avenues for therapeutic applications.

Her role as a research mentor is also notable, with five Ph.D. students having completed their dissertations under her supervision and four currently engaged in ongoing research projects. The diversity of her students’ research topics, ranging from nanotechnology to proteomics and biosurfactants, reflects her broad expertise and dedication to fostering new scientific talent.

Accolades and Recognition 🏅

Throughout her academic and professional career, Dr. Kumari has earned several accolades. Early in her career, she cleared the prestigious National Eligibility Test (NET) for Junior Research Fellowship (JRF) in 2004, a significant achievement that reflects her academic excellence. This was followed by the Senior Research Fellowship (SRF) awarded by the University Grants Commission (UGC) in 2006, which supported her doctoral research for three years.

Dr. Kumari is also an active member of the scientific community. She holds lifetime memberships with the Association of Microbiologists of India (AMI) and the Microbiologist Society of India (MSI), highlighting her commitment to contributing to and staying updated with developments in microbiology.

Impact and Influence 🌍

Dr. Kumari’s influence extends beyond academia, with her research impacting both clinical and environmental applications. Her work on bacteriophages as therapeutic agents offers potential solutions to the growing problem of antibiotic-resistant bacteria, an issue that poses significant challenges to modern healthcare. Furthermore, her studies on biosurfactants provide eco-friendly alternatives for industrial and medical applications, contributing to sustainable solutions in the fight against microbial infections.

Her numerous research publications, including 19 research articles and three book chapters, have added significant value to the global scientific community. Notably, her chapter on the application of therapeutic phages in medicine and her insights into the microbiota-gut-brain axis highlight the interdisciplinary nature of her work, bridging microbiology with other critical fields such as neuroscience and pharmacology.

Legacy and Future Contributions 🔮

Dr. Seema Kumari’s legacy lies in her relentless pursuit of innovative solutions to combat infectious diseases. By training a new generation of scientists and contributing cutting-edge research, she continues to influence the field of microbiology both in India and internationally. Her ongoing research on antimicrobial resistance, nanotechnology, and medicinal plants promises to make significant strides in developing effective and sustainable treatments for various health challenges.

Looking forward, her work is expected to further explore precision medicine, particularly the application of bacteriophages and nanocomposites in targeting specific pathogens with minimal side effects. Her vision for integrating biotechnology and microbiology will likely play a critical role in shaping the future of therapeutic interventions in the microbial realm.

Dr. Kumari’s commitment to research, teaching, and innovation ensures that her contributions will continue to resonate across academic and medical communities, leaving a lasting impact on both present and future scholars and practitioners.

🎓Publication 

Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice

  • Authors   :Sanjay Chhibber, Sandeep Kaur, Seema Kumari
  • Journal    :Journal of medical microbiology
  • Year         :2008

Bacteriophage versus antimicrobial agents for the treatment of murine burn wound infection caused by Klebsiella pneumoniae B5055

  • Authors   :Seema Kumari, Kusum Harjai, Sanjay Chhibber
  • Journal    :Journal of medical microbiology
  • Year         :2011

Efficacy of bacteriophage treatment in murine burn wound infection induced by Klebsiella pneumoniae

  • Authors   :Seema Kumari, Kusum Harjai, Sanjay Chhibber
  • Journal    :Journal of Microbiology and Biotechnology
  • Year         :2009

Topical treatment of Klebsiella pneumoniae B5055 induced burn wound infection in mice using natural products

  • Authors   :Seema Kumari, Kusum Harjai, Sanjay Chhibber
  • Journal    :The Journal of Infection in Developing Countries
  • Year         :2010

Prof Dr . Vinicius Schmitz Nunes| Inflammation|Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr . Vinicius Schmitz Nunes| Inflammation|Best Researcher Award

Prof Dr . Vinicius Schmitz Nunes at Universidade Federal do Rio de Janeiro,Brazil

PROFILE  

Orcid

Early Academic Pursuits 🎓

Vinicius Schmitz Nunes began his academic journey with a strong foundation in both Biology and Physics, earning a B.S. degree from the Universidade Federal de Juiz de Fora (UFJF) in July 2005. This dual background provided him with a versatile understanding of life sciences and physical sciences, which later became crucial in his multidisciplinary research endeavors. His curiosity about how biological processes could be examined through the lens of physics led him to pursue a Ph.D. in Computational Biology at the same institution, which he completed in December 2015. His doctoral studies laid the groundwork for his future research in molecular dynamics simulations and biophysics, shaping him into a prominent figure in the study of membrane proteins, particularly G-protein-coupled receptors (GPCRs).

Professional Endeavors 👨‍🏫

After completing his Ph.D., Nunes expanded his research through a postdoctoral fellowship in Biophysics at the Universidade Federal do Triângulo Mineiro and Laboratório Nacional de Computação Científica in Petrópolis, Brazil, from 2022 to 2023. During this period, he honed his expertise in molecular simulations, contributing to advancing computational biology, especially in protein-ligand interactions and drug design.

In 2023, he was appointed as a Visiting Professor at the Universidade Federal do Rio de Janeiro (UFRJ). Here, he continued to lead innovative research while mentoring the next generation of scientists in computational biology and biophysics. His role at UFRJ includes not only advancing his research but also teaching and collaborating with international researchers.

Contributions and Research Focus 🔬

Since 2018, Vinicius Schmitz Nunes has been actively researching membrane proteins—with a specific focus on G-protein-coupled receptors (GPCRs)—using molecular dynamics simulations. GPCRs are a large family of membrane proteins that play critical roles in cellular signaling and are important targets for drug development. His research aims to elucidate the activation mechanisms of these receptors and their interaction with various ligands.

A significant milestone in his career came in 2021 when he began working with Professor Charles Nicholas Serhan at Harvard Medical School. Together, they explored the role of Specialized Pro-resolving Mediators (SPMs) in inflammation and their interaction with GPCR receptors. This collaboration resulted in groundbreaking findings regarding receptor activation mechanisms, particularly how SPMs modulate the activity of GPCRs to resolve inflammation.

In addition to his work on SPMs and GPCRs, Nunes has demonstrated proficiency in molecular docking simulations, virtual screening, and structure-based drug design. His work in these areas has important implications for the development of new therapeutic agents, including antivirals and anti-inflammatory drugs. Notably, his contribution to the virtual screening of antivirals for SARS-CoV-2 non-structural proteins in 2021 gained considerable attention during the COVID-19 pandemic.

Accolades and Recognition 🏆

Throughout his career, Nunes has been recognized for his scientific contributions, particularly in computational biology and biophysics. His research has been published in high-impact scientific journals, reflecting the significance of his work. Some of his notable publications include:

  • “Insights into the Activation Mechanism of the ALX/FPR2 Receptor” (2020) in Journal of Physical Chemistry Letters—a pivotal paper that provided new insights into how the ALX/FPR2 receptor is activated by specialized ligands.
  • “ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation” (2023) in The Journal of Physical Chemistry—a collaboration with Professor Serhan that deepened the understanding of SPM receptor interactions.
  • “Leukotriene B4 receptor 1 (BLT1) activation by leukotriene B4 (LTB4) and E Resolvins (RvE1 and RvE2)” (2024) in Computational Biology and Chemistry—a study that revealed how leukotriene receptors respond to inflammatory mediators, shedding light on new potential drug targets.
  • “Antivirals virtual screening to SARS-CoV-2 non-structural proteins” (2021) in Journal of Biomolecular Structure & Dynamics—a timely contribution to the global effort against the COVID-19 pandemic.

Impact and Influence 🌍

Nunes’ work has had a significant impact on multiple scientific fields, including inflammation biology, GPCR pharmacology, and drug discovery. His research on the activation mechanisms of GPCRs is particularly influential, as GPCRs are involved in numerous physiological processes and are targets for a large percentage of therapeutic drugs. By using molecular dynamics simulations, he has provided detailed insights into receptor-ligand interactions, which could lead to the development of more effective and specific drugs for various diseases, including cancer, autoimmune diseases, and COVID-19.

His collaboration with Harvard Medical School has expanded his influence internationally, as his findings on Specialized Pro-resolving Mediators (SPMs) have important implications for understanding inflammation resolution—a key process in various diseases.

Legacy and Future Contributions 🌟

Vinicius Schmitz Nunes’ contributions to the fields of computational biology and biophysics are poised to leave a lasting legacy. His interdisciplinary approach, combining biology, physics, and computational techniques, allows him to explore complex biological questions with precision and depth. His work on GPCRs and inflammation resolution is laying the foundation for future research in drug development, particularly for conditions involving chronic inflammation and immune dysregulation.

In the future, Nunes is expected to continue his cutting-edge research, particularly in the field of structure-based drug design. His insights into molecular dynamics and virtual screening will likely influence how new therapeutic agents are designed, ensuring that his work remains at the forefront of computational biology for years to come. His role as a visiting professor at UFRJ will further solidify his legacy as a mentor and thought leader in the scientific community.

With his deep expertise, international collaborations, and impactful publications, Vinicius Schmitz Nunes is well-positioned to continue making significant contributions to biophysics, computational biology, and pharmacology, influencing both academic research and practical drug development.

🎓Publication 

ALX/FPR2 Activation by Stereoisomers of D1 Resolvins Elucidating with Molecular Dynamics Simulation

  • Authors   :Vinicius S. Nunes; Odonírio Abrahão, Jr.; Alexandre P. Rogério; Charles N. Serhan
  • Journal    :Physical Chemistry B
  • Year         :2023

Insights into the Activation Mechanism of the ALX/FPR2 Receptor

  • Authors   :Vinicius Schmitz Nunes; Alexandre P. Rogério; Odonírio Abrahão, Jr.
  • Journal    :Physical Chemistry Letters
  • Year         :2020

 

Dr. Stephen Weber| Regulatory Affairs|Best Researcher Award

Published on by Top Pharmaceutical

Dr. Stephen Weber| Regulatory Affairs|Best Researcher Award

Dr. Stephen Weber at The Johns Hopkins School of Medicine,United States

PROFILE  

scopus

🎓📚Education and Training:

  • University of Michigan, B.S. in Psychology/Zoology (1976), with high honors and Phi Beta Kappa.
  • University of Michigan Medical School, M.D. (1980), recognized as a Grossman Fellowship Recipient and member of Alpha Omega Alpha.
  • Completed internship and residency at the University of California, Davis (1981-1985).
  • Completed advanced fellowships in Fracture Surgery in Switzerland (1985) and Arthroscopy in Virginia (1986).

✅🏅Academic and Professional Appointments:

  • Assistant Professor of Orthopedics, Johns Hopkins School of Medicine, focusing on shoulder surgery since 2016.
  • Clinical and team physician roles at prestigious institutions, including University of California, Davis, and professional sports organizations.
  • Orthopedic practice experience at Sacramento Knee and Sports Medicine (1986-2016).

📖📝Regulatory Science Expertise:

  • Former Medical Officer at the FDA (2016-2019), with leadership in reviewing orthopedic devices, including shoulder arthroplasty and biologics.
  • Published numerous peer-reviewed articles and FDA white papers on biologic responses to metal implants, real-world evidence, and SMART devices.

🏆🎖️Certifications and Awards:

  • Board-certified by the American Board of Orthopaedic Surgery with a Sports Medicine Subspecialty.
  • Recipient of the Lifetime Achievement Award and Neer Circle honors from AAOS.
  • Multiple editorial positions, including the Journal of Shoulder and Elbow Surgery and the American Journal of Sports Medicine.

🎓Publication 

Incidence of anatomic total shoulder arthroplasty vs. reverse total shoulder arthroplasty in cuff intact osteoarthritis in males vs. females 70 years or older

  • Authors   :Navarro, R.A., Kody, M.T., Sanchez-Sotelo, J., … Taylor, S.A., Williams, G.R.
  • Journal    :Seminars in Arthroplasty JSES
  • Year         :2024

Iatrogenic Excessive Clavicle Resection as a Complication of Arthroscopic Distal Clavicle Excision

  • Authors   : Meshram, P., Saggar, R., Lukasiewicz, P., … Weber, S.C., McFarland, E.G.
  • Journal    :Orthopedics,
  • Year         :2024

Staying out of trouble: FDA regulation of orthobiologics and the shoulder surgeon

  • Authors   : Weber, S.C., McFarland, E.G.
  • Journal    :Journal of Shoulder and Elbow Surgery
  • Year         :2024

Editorial Commentary: Arthroscopic Bone Grafting Using Suspensory Fixation for Anterior Glenohumeral Fixation With Bone Loss May Supersede the Latarjet Procedure Using Coracoid Transfer

  • Authors   :Weber, S.C.
  • Journal    :Journal of Arthroscopic and Related Surgery
  • Year         :2024

American Shoulder and Elbow Surgeons perspectives on political advocacy

  • Authors   :Cronin, K.J., Calcei, J.G., Port, J., … Gulotta, L., Schlegel, T.F.
  • Journal    :Journal of Shoulder and Elbow Surgery
  • Year         :2024

 

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Ana Catarina Sousa| Personalized Medicine|Best Researcher Award

Mrs. Ana Catarina Sousa at School of Medicine and Biomedical Sciences – University of Porto (ICBAS),Portugal

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Ana Catarina Soares de Sousa’s academic journey is marked by a strong focus on the intersection of healthcare and engineering. She completed her Master’s degree in Health Services Management and Economics in 2021 at the prestigious University of Porto, one of the top academic institutions in Portugal. This degree provided her with in-depth knowledge of the economic and managerial aspects of healthcare services, a vital skill set for navigating the complexities of healthcare systems and improving service delivery.

Prior to this, she earned a Master’s degree in Integrated Master in Bioengineering in 2018 at the same university. This program combined principles of biology, medicine, and engineering, equipping her with a solid foundation in biomedical engineering—particularly crucial for her subsequent research on biomaterials and medical technologies. Her dual educational background uniquely positions her to address both the technical and systemic challenges in health services, a hallmark of her later work.

Since 2020, Ana Catarina has been pursuing a PhD in Biomedical Sciences at the Abel Salazar Institute of Biomedical Sciences (ICBAS) within the University of Porto. Her PhD program focuses on interdisciplinary research in medical and health sciences, allowing her to build on her expertise in biomaterials and tissue engineering, while contributing to innovations in medical biotechnology.

Professional Endeavors 💼

Ana Catarina’s professional journey reflects a commitment to both research and practical applications in the biomedical sciences. Throughout her career, she has participated in numerous research projects, taking on key roles both as a research fellow and a lead researcher. Since 2018, she has contributed to seven major research projects, focusing on cutting-edge biomedical technologies and solutions for healthcare challenges.

Among her significant projects are:

  • InnovaBIOMAS (2023–2026): An innovative biofabrication system for creating multi-tissue scaffolds for joint disease treatments. This project highlights her expertise in biomaterials and tissue engineering.
  • H2Cure (2021–2024): A project developing novel formulations, including honey-based gels and dressings with gelan gum and hyaluronic acid for wound care—an intersection of regenerative medicine and biotechnology.
  • PRECOGFIL (2020–2024): This initiative explores the development of pre-tensioned cog threads for transvaginal repair of compartment prolapse, showing her application of bioengineering in women’s health.
  • Bone2Move (2018–2021): Focused on 4D scaffolds for bone defect repair, it underscores her involvement in the evolution of tissue engineering techniques.

Her work has crossed the boundaries of disciplines, spanning medical technology, veterinary applications, regenerative medicine, and materials engineering.

Contributions and Research Focus 🔬

Ana Catarina’s contributions to the biomedical field have been prolific. With 30 peer-reviewed journal articles and 2 book chapters, she has established herself as a thought leader in the scientific community. Her research encompasses a range of fields, but she is particularly recognized for her work in Medical Biotechnology, with a specific emphasis on biomaterials and tissue engineering.

Some of the key areas of her research include:

  • Regenerative Medicine: Her focus on developing advanced biomaterials that can aid in tissue regeneration and healing has practical applications in orthopedics, wound care, and surgical interventions.
  • Veterinary Medicine: Her interdisciplinary approach extends into veterinary science, where she applies biomedical engineering techniques to animal health.
  • Translational Medicine: Ana Catarina is committed to bridging the gap between laboratory research and clinical applications, ensuring that her discoveries can have a real-world impact on patient care.
  • Sustainable Chemistry: She has also been involved in developing environmentally friendly materials and chemical processes for healthcare applications, contributing to sustainability in medical technology.
  • Chemistry for Health: Her work in this area includes the development of biomaterials and formulations aimed at improving health outcomes through innovative chemistry.

With 214 co-authors in her published works, she has demonstrated an impressive ability to collaborate across disciplines and with researchers from around the world.

Accolades and Recognition 🏆

Ana Catarina’s work has not gone unnoticed. She has been the recipient of one award that recognizes her contributions to the field of biomedical sciences. This accolade highlights her innovative approach to healthcare challenges and her ability to bring together diverse disciplines in pursuit of improved health outcomes.

In addition to her award, she has also been instrumental in the scientific community as an event organizer. She has successfully organized three major events, bringing together researchers, healthcare professionals, and industry experts to discuss the latest advancements in biomedical sciences and medical technologies.

Impact and Influence 🌍

Ana Catarina’s work in biomedical sciences has the potential to make a far-reaching impact on both human and animal health. By focusing on innovative biomaterials and medical biotechnology, she is contributing to the development of new treatments that could transform the way diseases are managed and treated. Her research on scaffold-based tissue regeneration and wound care formulations has implications for patients suffering from joint diseases, chronic wounds, and surgical complications.

Her work in the development of advanced biofabrication systems and pre-tensioned threads for surgical repairs also promises to improve surgical outcomes and post-surgical recovery for patients. Moreover, her focus on sustainable chemical processes ensures that her contributions are not only medically valuable but also environmentally responsible.

Legacy and Future Contributions 🌟

Looking ahead, Ana Catarina is poised to continue making groundbreaking contributions to the field of biomedical sciences. Her ongoing projects, particularly those related to biomaterials for regenerative medicine, have the potential to lead to new therapies that will benefit both human and veterinary medicine.

Her focus on translational research ensures that her work will continue to have a direct impact on clinical practices, making her a key figure in the future of medical biotechnology. As she progresses in her PhD journey and beyond, Ana Catarina Soares de Sousa is likely to leave a lasting legacy in the fields of tissue engineering and healthcare innovation.

In the years to come, her work is expected to influence not only scientific research but also the development of new medical technologies that will improve patient care and healthcare systems around the world.

🎓Publication 

Peripheral nerve injury treatments and advances: one health perspective

  • Authors   :Bruna Lopes, Patrícia Sousa, Rui Alvites, Mariana Branquinho, Ana Catarina Sousa, Carla Mendonça, Luís Miguel Atayde, Ana Lúcia Luís, Artur SP Varejão, Ana Colette Maurício
  • Journal    :International journal of molecular sciences
  • Year         :2022

Dental pulp stem cells and Bonelike® for bone regeneration in ovine model

  • Authors   : JM Campos, AC Sousa, AR Caseiro, SS Pedrosa, PO Pinto, MV Branqu
  • Journal    :Regenerative biomaterials
  • Year         :2019

Mesenchymal stem/stromal cells and their paracrine activity—immunomodulation mechanisms and how to influence the therapeutic potential

  • Authors   : Rui Alvites, Mariana Branquinho, Ana C Sousa, Bruna Lopes, Patrícia Sousa, Ana Colette Maurício
  • Journal    :Pharmaceutics
  • Year         :2022

Assessment of the environmental impacts of medical devices: a review

  • Authors   :Ana Catarina Sousa, Anabela Veiga, Ana Collete Maurício, Maria Ascensão Lopes, José Domingos Santos, Belmira Neto
  • Journal    :Environment, Development and Sustainability
  • Year         :2021

Combined Use of Chitosan and Olfactory Mucosa Mesenchymal Stem/Stromal Cells to Promote Peripheral Nerve Regeneration In Vivo

  • Authors   :Rui D Alvites, Mariana V Branquinho, Ana C Sousa, Irina Amorim, Rui Magalhães, Filipa João, Diogo Almeida, Sandra Amado, Justina Prada, Isabel Pires, Federica Zen, Stefania Raimondo, Ana L Luís, Stefano Geuna, Artur SP Varejão, Ana C Maurício
  • Journal    :Stem cells international
  • Year         :2021

 

Mr. Yeniewa Anagaw| Pharmacy|Best Researcher Award

Published on by Top Pharmaceutical

Mr. Yeniewa Anagaw| Pharmaceutical Pharmacy
|Best Researcher Award

Mr. Yeniewa Anagaw at Medical University of Gondar,Ethiopia

PROFILE  

scopus

Google scholar

Early Academic Pursuits 📚

Yeniewa Kerie Anagaw’s journey in academia began with his Bachelor of Pharmacy degree from Miza-Tepi University, Ethiopia, in 2016. Graduating with a commendable cGPA of 3.39/4.00, his directed study explored a critical area of public health, specifically focusing on tuberculosis treatment outcomes and predictors among HIV patients in Southwest Ethiopia. This early research demonstrated his keen interest in addressing significant health challenges affecting his community. He continued his academic growth with a Master of Science in Pharmaceutical Analysis and Quality Assurance at Addis Ababa University, where he earned an impressive cGPA of 3.81/4.00. His thesis, titled “Analytical Method Development and Validation Based on Paper Analytical Device (PAD) for Adulteration Detection in Teff Injera (Ethiopian flatbread),” highlights his dedication to innovation in pharmaceutical analysis and public health. This work, which employed Microwave Plasma Atomic Emission Spectroscopy (MP-AES), underscores his analytical and scientific rigor.

Professional Endeavors and Teaching Commitments 👨‍🏫

Yeniewa’s professional career took off in December 2016 when he joined Finote Selam General Hospital as a junior pharmacist. In this role, he participated in ward rounds and patient chart reviews, where he helped identify, prevent, and mitigate drug-related problems. His responsibilities included ensuring appropriate drug selection and dosage, managing adverse drug reactions, addressing drug interactions, and preparing compounded dermatological formulations. Yeniewa also worked as a pharmacy coordinator, showcasing his leadership and organizational skills early in his career.

By January 2018, Yeniewa transitioned into academia as an assistant lecturer at the University of Gondar’s School of Pharmacy. In this role, he supervised and instructed undergraduate students in Pharmaceutical Analysis laboratory sessions, focusing on hands-on training in instrumental analysis and data interpretation. His role expanded to delivering lectures in Pharmaceutical Analysis, Pharmacy Practice, and Quality Control and Assurance. Yeniewa’s dynamic teaching style, coupled with his passion for research, has made him a pivotal figure in shaping future pharmacists.

Since April 2022, Yeniewa has held a lecturer position at the University of Gondar. Here, his responsibilities have evolved to include not only lecture preparation and delivery but also student mentoring, exam evaluation, and practical learning experiences. Yeniewa’s teaching covers Electroanalytical Methods, IR Spectroscopy, NMR, HPLC, and Mass Spectrometry (MS), which are crucial tools in the field of pharmaceutical science. His ability to guide students through both theoretical and practical knowledge demonstrates his comprehensive approach to education.

Contributions and Research Focus 🔬

Yeniewa’s research interests span across various domains within pharmaceutical sciences, including pharmaceutical analysis, quality assurance, proteomics, metabolomics, drug delivery, and biomarker discovery. His dedication to research is reflected in his published works and his involvement in grant writing for school projects. Yeniewa is particularly passionate about developing analytical methods for drug adulteration detection, exemplified by his thesis on detecting adulterants in Teff Injera. This research is crucial for ensuring food safety and protecting public health.

Additionally, Yeniewa has participated in several community service initiatives. One notable contribution involved the quantitative analysis of table salt used for wound cleaning, showcasing his commitment to improving healthcare practices in Ethiopia. His engagement in such community-oriented projects demonstrates his desire to translate academic research into practical solutions that benefit society.

Accolades and Recognition 🏅

Throughout his career, Yeniewa has earned various certificates and recognition for his contributions to both academia and the pharmaceutical field. Some of his notable achievements include:

  • Certificate of the training workshop on “Anticancer Medicines Quality Evaluation Using the Chemo-spot System.”
  • BMJ Open Reviewer’s Certificate and Peer Reviewer Verification Certificates from Springer Nature, which highlight his contributions to scientific literature through peer review.
  • Presenter Certificate at the “42nd Annual Scientific Conference of the Ethiopia Pharmacy Association (EPA),” where he shared his research with a broader scientific community.
  • Certificates for attending workshops and training sessions on research enhancement, intellectual property, and good manufacturing practices (GMP), indicating his commitment to continuous professional development.

Impact and Influence 🌍

Yeniewa’s influence extends beyond his immediate academic and professional circles. His research on tuberculosis treatment and pharmaceutical adulteration contributes to public health advancements, particularly in Ethiopia. By addressing key issues in drug safety and treatment optimization, he has played a role in enhancing healthcare outcomes for vulnerable populations. As a lecturer, Yeniewa has directly impacted the education of future pharmacists, providing them with the knowledge and skills necessary to excel in both clinical and research settings. His involvement in grant writing and school projects also demonstrates his efforts to foster research initiatives that could have far-reaching benefits.

Legacy and Future Contributions 🌟

As Yeniewa continues his career, his focus remains on bridging the gap between pharmaceutical research and practical healthcare solutions. His expertise in proteomics, drug discovery, and spectroscopic methods positions him as a valuable contributor to ongoing efforts in pharmaceutical innovation. Furthermore, his dedication to teaching ensures that future generations of pharmacists are well-equipped to tackle emerging challenges in the field.

Yeniewa’s future contributions are likely to leave a lasting legacy, both in terms of academic excellence and practical healthcare improvements. His adaptability, hard work, and passion for both teaching and research will continue to drive his success as he navigates the evolving landscape of pharmaceutical sciences.

🎓Publication 

Outcome of tuberculosis treatment and its predictors among HIV infected patients in southwest Ethiopia

  • Authors   :Adane Teshome Kefale, Yeniewa Kerie Anagaw
  • Journal    :International Journal of General Medicine
  • Year         :2017

Assessment of community pharmacy professionals’ willingness, involvement, beliefs, and barriers to offer health promotion services: a cross-sectional study

  • Authors   : Wondim Ayenew, Abdulwase Mohammed Seid, Asmamaw Emagn Kasahun, Asrat Elias Ergena, Derso Teju Geremaw, Liknaw Workie Limenh, Teshome Bitew Demelash, Wudneh Simegn, Yeniewa Kerie Anagaw, L.
  • Journal    :BMC Health Services Research
  • Year         :2022

Assessment of Knowledge, Attitudes, and Practices of Traditional Healers toward Dosage Forms and Routes of Administration: A Cross‐Sectional Study in Ethiopia

  • Authors   : Liknaw Workie Limenh, Derso Teju Geremew, Asmamaw Emagn Kasahun, Yeniewa Kerie Anagaw, Minichil Chanie Worku, Wudneh Simegn, Wondim Ayenew
  • Journal    :Evidence‐Based Complementary and Alternative Medicine
  • Year         :2023

Assessment of knowledge, attitude, and practice on substandard and counterfeit pharmaceutical products among pharmacy professionals in Gondar City, North-West Ethiopia

  • Authors   :Minichil Chanie Worku, Melese Legesse Mitku, Wondm Ayenew, Liknew Workie Limenh, Asrat Elias Ergena, Derso Teju Geremew, Gizachew Kassahun Bizuneh, Bereket Bahiru Tefera, Biset Asrade Mekonnen, Yeniewa Kerie Anagaw
  • Journal    :Currents in Pharmacy Teaching and Learning
  • Year         :2024

Prevalence and predictors of self-medication with antibiotics in Ethiopia: a systematic review and meta-analysis

  • Authors   :Wondim Ayenew, Tewodros Ayalew Tessema, Yeniewa Kerie Anagaw, Ebrahim Abdela Siraj, Segenet Zewdie, Wudneh Simegn, Liknaw Workie Limenh, Chernet Tafere, Ashagrachew Tewabe Yayehrad
  • Journal    :Antimicrobial Resistance & Infection Control
  • Year         :2024

Mrs. Mariya Ivanova| Pharmaceutical Policy and Regulation|Best Researcher Award

Published on by Top Pharmaceutical

Mrs. Mariya Ivanova| Pharmaceutical Policy and Regulation|Best Researcher Award

Mrs. Mariya Ivanova at Medical University of Varna,Bulgaria

PROFILE  

scopus

Early Academic Pursuits 🎓

Mariya Mitkova Ivanova, born on July 17, 1976, laid the foundation for her distinguished career with an education grounded in healthcare and pharmaceutical sciences. She began her journey at Medical College, earning a degree in “Assistant Pharmacist,” a role that sparked her interest in the broader field of pharmacy. Her academic ambitions led her to pursue a Master’s degree in Applied Psychology at Varna Free University (VFU) “Chernorizets Hrabar.” This unique combination of pharmaceutical knowledge and psychological insight set the stage for her future research focus on professional burnout.

To further solidify her credentials in the healthcare domain, Mariya pursued a second Master’s degree in Pharmacy at the Faculty of Pharmacy, Medical University of Varna. She later specialized in the “Organization and Economics of the Distributor and Pharmacy Practice,” which offered her deep insights into the operational side of the pharmaceutical profession. These experiences, both theoretical and practical, culminated in her PhD in “Social Medicine and Organization of Health and Pharmacy,” with her doctoral thesis focusing on professional burnout within the pharmaceutical field.

Professional Endeavors 💼

Mariya Ivanova’s career spans over two decades of dedicated service in the pharmaceutical profession. From 1999 to 2022, she worked as a pharmacist in a community pharmacy setting, offering essential healthcare services to the public. This experience was instrumental in her understanding of the practical challenges faced by pharmacists, which later informed her academic research on burnout and professional stress in the healthcare sector.

In 2019, she transitioned into academia as an assistant professor at the Department of Organization and Economics of Pharmacy at the Medical University of Varna. Her expertise and dedication earned her a promotion to chief assistant professor in 2023. Her academic role focuses on improving pharmacy care and policy, with a particular emphasis on preventing professional burnout. She continues to blend her practical experience with her academic knowledge to train the next generation of healthcare professionals.

Contributions and Research Focus 🔬

Mariya Ivanova’s research primarily revolves around the well-being of healthcare professionals, specifically pharmacists, who often face immense pressure in their day-to-day responsibilities. Her PhD dissertation, “Professional Burnout and Development of the Pharmaceutical Profession,” delved into the occupational challenges and mental health risks associated with the profession.

One of her significant completed research projects is № 20018 titled “Current Trends and Professional Stress in Pharmaceutical Services,” funded by the Medical University of Varna’s “Nauka” Fund. This project examined the stressors faced by pharmacists and proposed methods to alleviate these pressures. She is currently working on another project funded by “Nauka” titled “Integrated Strategies and Models for Preventing Professional Burnout and Coping with Stress Among Healthcare Professionals.”

Her contributions to pharmaceutical care extend beyond theoretical research. She has identified key burnout factors, including those exacerbated by the COVID-19 pandemic, and developed practical tools like an informational booklet on the causes of burnout and strategies to prevent it. This work aims to assist practicing pharmacists in managing their mental health and improving their professional environment.

Accolades and Recognition 🏆

Throughout her career, Mariya Ivanova has garnered recognition for her work both within academia and the healthcare community. Her research on burnout prevention has earned her a growing citation index, with an h-index of 2 on Google Scholar and 1 on ResearchGate. Her scholarly contributions are frequently cited in discussions about pharmacy policy and healthcare worker well-being.

As a member of the Bulgarian Pharmaceutical Union, Mariya actively contributes to the professional development of pharmacists in Bulgaria. She also serves as a reviewer for Dove Press, showcasing her expertise and influence in the scientific community.

Impact and Influence 🌟

Mariya Ivanova’s work has had a profound impact on the understanding of professional burnout among pharmacists, particularly during the stressful period of the COVID-19 pandemic. By identifying the key factors that contribute to burnout, she has provided valuable insights that can help improve the working conditions for pharmacists. Her research is already being used to streamline administrative processes in pharmacies, freeing up time and resources for pharmacists to focus on patient care.

Moreover, her research has broader implications for the entire healthcare sector, as burnout is a widespread issue affecting various professionals. The strategies she has developed for pharmacists could easily be adapted for other healthcare workers, contributing to the overall well-being of medical staff.

Legacy and Future Contributions ✨

As she continues to build on her academic and professional accomplishments, Mariya Mitkova Ivanova is poised to leave a lasting legacy in the field of pharmaceutical care and healthcare worker well-being. Her ongoing project on integrated strategies for preventing burnout among healthcare professionals promises to offer valuable solutions to one of the most pressing issues in modern healthcare.

Looking ahead, Mariya aims to expand her research into global contexts, applying her findings to healthcare systems outside Bulgaria. Her work could influence international pharmacy policies and contribute to global efforts to improve the mental health and job satisfaction of healthcare professionals.

With her commitment to improving pharmacy care and her contributions to the understanding of professional burnout, Mariya Ivanova’s work will continue to resonate in both academic and practical spheres, impacting the healthcare profession for years to come.

🎓Publication 

Pharmacists’ burnout and motivation for pharmaceutical care in chronically ill patients -a pilot study for the north-eastern region of Bulgaria

  • Authors   :Todorova, A., Ivanova, M., Petkova, V.
  • Journal    :Pharmacia
  • Year         :2017

Prevalence and risk factors of burnout among community pharmacists in Northeast region of Bulgaria – a pilot study

  • Authors   : Ivanova, M., Todorova, A., Georgieva, L.
  • Journal    :Pharmacia,
  • Year         :2023

Dr. ANANDARUP GOSWAMI| Drug Discovery and Developmenty|Best Researcher Award

Published on by Top Pharmaceutical

Dr. ANANDARUP GOSWAMI| Drug Discovery and Development|Best Researcher Award

Dr. ANANDARUP GOSWAMI at Vignan’s Foundation for Science, Technology and Research,India

PROFILE  

Google scholar

Early Academic Pursuits 🎓

Dr. Anandarup Goswami’s passion for chemistry was ignited during his early years of education. He completed his undergraduate studies with a B.Sc. (Hons.) in Chemistry from the prestigious Presidency University in Kolkata, one of India’s top institutions for the sciences. He further honed his expertise by pursuing an M.Sc. in Chemistry at the renowned Indian Institute of Technology (IIT) Kanpur, known for producing some of the finest scientific minds in the country. Dr. Goswami’s dedication to his academic pursuits earned him a place in Cornell University, USA, where he completed his Ph.D. His doctoral work marked the beginning of his contribution to cutting-edge research, where he specialized in advanced areas of chemistry. His journey did not stop there; he went on to complete his postdoctoral research at Rutgers University, USA, and Palacky University, Czech Republic, enhancing his research portfolio and gaining exposure to diverse scientific methodologies and innovative research techniques.

Professional Endeavors 🧪

Dr. Anandarup Goswami joined Vignan’s Foundation for Science, Technology and Research (VFSTR) as an Associate Professor in November 2026. His professional career spans a broad spectrum of roles, from teaching and mentoring students to leading groundbreaking research. He has served as a Ph.D. supervisor and has guided numerous students in drug degradation studies and nanocatalysis development for environmental applications. His work at VFSTR has helped shape the future of young scientists while driving forward critical research in sustainable chemistry.

Dr. Goswami also holds numerous editorial appointments, including being a member of the Editorial Board of Current Indian Science (Bentham) and a Review Editor for Green and Sustainable Chemistry (Frontiers). His contributions to these roles highlight his prominence in the scientific community, where he is trusted to review and oversee publications in these significant areas of research.

Contributions and Research Focus 🔬

Dr. Goswami’s research contributions are primarily centered around two critical areas: pharmaceutically relevant compounds and sustainable nanocatalysts. His extensive work in the isolation and in-depth characterization of degradation products of pharmaceutical compounds has significant implications for drug safety, efficacy, and regulatory science. In tandem, his pioneering work on the development of nanocatalysts for environmental applications addresses pressing issues related to sustainability and environmental protection.

Dr. Goswami’s work emphasizes catalysis, energy conversion, and material science, offering solutions to some of today’s most critical challenges. His contributions span more than 50 peer-reviewed publications, including in highly reputed journals such as Journal of the American Chemical Society (JACS), Angewandte Chemie, and Nature Chemistry. Moreover, his book, Solvent-Free Methods in Nanocatalysis: From Catalyst Design to Applications, co-edited with prominent scientists, reflects his authority in the field of nanocatalysis.

Accolades and Recognition 🏆

Dr. Goswami’s research accomplishments have been widely recognized in the scientific community. With an h-index of 27 on Google Scholar and 26 on Scopus, along with more than 8,800 citations, his work has made a lasting impact on his field. He has received recognition for his contributions to nanocatalysis and drug degradation, and his research has gained international acclaim.

One of his notable patents, US010722743B2, titled Multicatalyst Polyelectrolyte Membranes and Methods of Utilizing the Same, was developed during his time at Rutgers University, USA. This patent reflects his innovative approach to solving complex problems in material science and catalysis.

Dr. Goswami’s contributions have also led him to collaborate with renowned scientists globally, including Prof. Tewodros Asefa from Rutgers University, USA, and Prof. Radek Zboril from RCPTM, Czech Republic. These collaborations have expanded his research’s scope and influence, enabling him to contribute to international advancements in chemistry.

🎓Publication 

Cu and Cu-Based Nanoparticles: Synthesis and Applications in Catalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, François-Xavier Felpin, Tewodros Asefa, Xiaoxi Huang, Rafael Silva, Xiaoxin Zou, Radek Zboril, Rajender S Varma
  • Journal    :Chemical reviews
  • Year         :2016

obalt‐Embedded Nitrogen‐Rich Carbon Nanotubes Efficiently Catalyze Hydrogen Evolution Reaction at All pH Values

  • Authors   : Xiaoxin Zou, Xiaoxi Huang, Anandarup Goswami, Rafael Silva, Bhaskar R Sathe, Eliška Mikmeková, Tewodros Asefa
  • Journal    :Angewandte Chemie International Edition
  • Year         :2014

Core–shell nanoparticles: synthesis and applications in catalysis and electrocatalysis

  • Authors   : Manoj B Gawande, Anandarup Goswami, Tewodros Asefa, Huizhang Guo, Ankush V Biradar, Dong-Liang Peng, Radek Zboril, Rajender S Varma
  • Journal    :Chemical Society Reviews
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   : Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature chemistry
  • Year         :2015

Covalent functionalization of monolayered transition metal dichalcogenides by phase engineering

  • Authors   :Damien Voiry, Anandarup Goswami, Rajesh Kappera, Cecilia de Carvalho Castro e Silva, Daniel Kaplan, Takeshi Fujita, Mingwei Chen, Tewodros Asefa, Manish Chhowalla
  • Journal    :Nature Publishing Group
  • Year         :2015

Assoc Prof Dr. Muhammad Raza| Medicinal Chemistry|Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Muhammad Razal Kotaska| Medicinal Chemistry|Best Researcher Award

Assoc Prof Dr. Muhammad Raza at University of Gujrat,Pakistan

PROFILE  

orcid

 

 

Early Academic Pursuits 🎓

Dr. Muhammad Asam Raza embarked on his academic journey with a strong foundation in the natural sciences. After completing his F.Sc. from the Board of Intermediate and Secondary Education, Gujranwala in 1998, he pursued a B.Sc. in Zoology, Botany, and Chemistry from the University of Punjab, Lahore. His profound interest in chemistry led him to continue his academic endeavors with an M.Sc. in Chemistry from the same institution, where his research centered on “Production of xylanases and cellulases in bioreactor by using Chaetomium thermophile.”

Dr. Raza’s pursuit of higher education took him to GC University, Lahore, where he earned both his M.Phil. and Ph.D. degrees in Chemistry. His M.Phil. research focused on the “Phytochemical and antioxidant screening of Mimusops elengi,” while his Ph.D. dissertation was centered on the “Extraction, structure elucidation, and microbial transformation of protease inhibitors from medicinal plants.” These early research topics highlight his passion for bioactive compounds and natural product chemistry, setting the stage for a career rich in scientific exploration.

Professional Endeavors 👨‍🏫

Dr. Raza’s academic and research career took off when he joined the University of Gujrat in 2011 as an Assistant Professor in the Department of Chemistry. Over the years, he contributed extensively to teaching and research at the institution, shaping the academic futures of numerous students. His dedication and excellence in the field of chemistry led to his promotion to Associate Professor in December 2020.

In addition to his role as a professor, Dr. Raza has held various administrative responsibilities at the University of Gujrat, including serving as the coordinator of the Four Year Degree Program in Chemistry, time table in-charge, and head examiner for the B.Sc./B.S. Program. His involvement in organizing industrial and study tours has further enriched the academic experiences of students, giving them a practical understanding of their field of study.

Contributions and Research Focus 🔬

Dr. Raza’s research portfolio is vast, focusing primarily on bioactive compounds, their purification, synthesis, and characterization. His expertise in chromatographic techniques, such as Thin Layer Chromatography (TLC), Column Chromatography, and High-Performance Liquid Chromatography (HPLC), has led to significant breakthroughs in the purification of bioactive compounds. He is also proficient in Gas Chromatography-Mass Spectrometry (GC-MS), enabling him to identify volatile compounds and elucidate the structures of synthesized and natural products.

His research interests also encompass microbial transformation, enzyme inhibition, antioxidant studies, and kinetic studies of various reactions. He has explored both natural and synthetic compounds for their antimicrobial and enzyme inhibition properties, significantly contributing to the field of medicinal chemistry. Additionally, Dr. Raza’s work on the production and characterization of xylanases and cellulases from fungal cultures demonstrates his expertise in enzyme technology, which holds potential for industrial applications.

Docking studies, using different software, have also been a significant focus in Dr. Raza’s research. This computational approach to studying molecular interactions has opened new avenues in drug design and development, further enhancing his contributions to the chemistry of biologically active molecules.

Accolades and Recognition 🏆

Throughout his career, Dr. Muhammad Asam Raza has received numerous accolades, reflecting his excellence in both academic and research fields. He was awarded a Merit Scholarship in 1997 from the District Council of Hafizabad, which was an early indicator of his potential. Later, he received the Indigenous PhD 5000 Fellowship Program from the Higher Education Commission (HEC) of Pakistan, a prestigious scholarship that supported his doctoral studies. Dr. Raza’s contributions to research were also acknowledged by the Pakistan Council for Science and Technology (PCST) with Research Productivity Awards in 2012 and 2013.

Further recognition of his expertise came when Dr. Raza was approved as a Ph.D. supervisor by the HEC, allowing him to mentor and guide future researchers in their academic pursuits. Additionally, he secured a research project worth half a million rupees from the HEC, demonstrating his ability to attract significant funding for his research endeavors.

Impact and Influence 🌍

Dr. Raza’s impact extends beyond the classroom and laboratory. His active participation in organizing national and international workshops, seminars, and symposiums has significantly contributed to the dissemination of knowledge in the scientific community. He has been instrumental in hosting events such as the “Two Days Interdisciplinary National Workshop on Chromatography & Mass Spectrometry” and the “Two Days International Symposium on Developments in Contemporary Chemistry” at the University of Gujrat.

His administrative roles have also been influential, particularly his contributions as a member of various departmental committees, including the Departmental Doctoral/MPhil Program Committee (DDMPC) and the Purchase Committee (NRPU). Dr. Raza’s participation in such committees highlights his commitment to improving the academic and research infrastructure at the University of Gujrat.

Furthermore, Dr. Raza’s work as a reviewer for scientific journals and project evaluator for research proposals under the NRPU has contributed to maintaining the standards of scientific inquiry in Pakistan. His expertise is frequently sought in assessing research proposals and reviewing academic papers, ensuring the advancement of chemistry research in the country.

Legacy and Future Contributions 🌱

Dr. Muhammad Asam Raza’s contributions to the field of chemistry, both in terms of research and teaching, have left a lasting legacy at the University of Gujrat and beyond. His commitment to advancing knowledge in bioactive compounds, enzyme inhibition, and molecular docking studies is not only reflected in his research but also in the numerous students he has mentored over the years.

Looking forward, Dr. Raza is poised to continue making significant contributions to the field of chemistry, particularly in the areas of natural product chemistry, enzyme technology, and computational drug design. His future work will likely focus on the synthesis and characterization of biologically active compounds, with potential applications in pharmaceuticals, agriculture, and biotechnology.

Dr. Raza’s legacy will undoubtedly be defined by his passion for chemistry, his dedication to teaching, and his tireless pursuit of scientific excellence, which will continue to inspire future generations of researchers.

🎓Publication 

Acetylcholine and butyrylcholine esterase inhibitory potential of newly synthesized halogenated compounds: In vitro, in silico and MD simulation

  • Authors   : emanur Yesilbağ; Muhammad Asam Raza; Zeshan Ali Sandhu; Umme Farwa; Emine Berrin Poyraz;
  • Journal    :Molecular Structure
  • Year         :2025

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

  • Authors   : Sandhu, Z.A.; Raza, M.A.; Alqurashi, A.; Sajid, S.; Ashraf, S.; Imtiaz, K.; Aman, F.; Alessa, A.H.; Shamsi, M.B.; Latif, M.
  • Journal    :Pharmaceutics
  • Year         :2024

Association of APO B gene polymorphisms with the development of myocardial infarction in Pakistani population

  • Authors   : Arshad, M.; Iqbal, R.; Raza, M.; Bashir, R.; Ahmed, T.; Parveen, A.
  • Journal    :Gene
  • Year         :2024

Beyond graphene: exploring the potential of MXene anodes for enhanced lithium–sulfur battery performance

  • Authors   : Zeshan Ali Sandhu; Kainat Imtiaz; Muhammad Asam Raza; Adnan Ashraf; Areej Tubassum; Sajawal Khan; Umme Farwa; Ali Haider Bhalli; Abdullah G. Al-Sehemi
  • Journal    :RSC Advances
  • Year         :2024

Biomedical properties, characterization of seaweeds species and antimicrobial activity,Propriedades biomédicas, caracterização de espécies de algas marinhas e atividade antimicrobiana

  • Authors   : Rizwan, S.; Saleem, M.; Hassan, H.U.; Raza, M.A.; Kanwal, R.; Kabir, M.; Ghaffar, R.A.; Fadladdin, Y.A.J.; Rafiq, N.; Matin, A. et al.
  • Journal    :Brazilian Journal of Biology
  • Year         :2024

Assoc Prof Dr. Karel Kotaska| Precision Medicine |Best Researcher Award

Published on by Top Pharmaceutical

Assoc Prof Dr. Karel Kotaska|Precision Medicine|Best Researcher Award

Assoc Prof Dr. Karel Kotaska at University Hospital Motol,Czech Republic

PROFILE  

orcid

 

🎓 Early Academic Pursuits

Kotaška’s academic journey began at the Sladkovského High School in Prague, where he completed his secondary education in 1992. Following this, he embarked on an educational path that laid the foundation for his career in biochemistry. In 1997, he graduated from the Institute of Chemical Technology in Prague, earning a Dipl. Ing. in Chemistry Engineering, specializing in Biomedical Engineering. His thirst for knowledge led him to pursue postgraduate studies at the 2nd Medical Faculty of Charles University, Prague, where he specialized in Biochemistry and Pathobiochemistry, culminating in a Ph.D. in 2003. His doctoral research and thesis defense were pivotal moments in shaping his future career as a leading figure in biochemistry.

🏢 Professional Endeavors

Kotaška’s professional career has spanned over two decades, beginning in 2002 at the Department of Medical Chemistry and Clinical Biochemistry at the University Hospital Motol, one of the largest medical facilities in the Czech Republic. As a research scientist and specialist, he quickly became an integral part of the team, contributing significantly to research projects and clinical laboratory functions. In 2015, Kotaška was appointed Associate Professor in Medical Chemistry and Clinical Biochemistry at the 2nd Medical Faculty of Charles University, further solidifying his standing as an expert in his field. His role expanded into quality management, becoming an auditor and overseeing laboratory processes to ensure adherence to ISO standards and good laboratory practices.

🔬 Contributions and Research Focus

Kotaška’s research interests are broad and impactful, covering various aspects of biochemistry and clinical diagnostics. His primary research focuses on the role of natriuretic peptides in cardiovascular diseases, a field critical for advancing the understanding and treatment of heart-related conditions. He has also made significant strides in investigating biomarkers associated with cardiovascular, neurological, inflammatory, and tumor diseases.

In addition to his contributions to molecular genetics, where he has explored genetic variants linked to diseases, Kotaška is well-versed in laboratory management and external quality control. He has been involved in the harmonization and standardization of laboratory practices, ensuring that diagnostics adhere to global standards. His work in urinalysis and infrared spectroscopy has also pushed forward diagnostic capabilities in clinical biochemistry.

🏆 Accolades and Recognition

Kotaška’s impressive career has not gone unnoticed. He has received numerous grant awards for his research, including projects funded by the Grant Agency of the Ministry of Health (MH) and Charles University. His studies have ranged from investigating biomarkers for organ failure to exploring the molecular biology of neurofibromatosis and cathepsin B activity in bladder carcinoma.

Notably, his project on the biological behavior of urological malignancies, which involved long-term monitoring of tissue, serum, and urine samples, stands out as a pioneering effort in the field of cancer research. Additionally, his ongoing work since 2021 on the effect of combined treatments in chronic heart failure in animal models has further contributed to advancing therapeutic approaches.

🌍 Impact and Influence

Beyond his laboratory work, Kotaška has made substantial contributions to academia and clinical education. Since 2008, he has been involved in teaching postgraduate students and has served as a lecturer at several institutions, including the Czech Technical University, where he taught biomedical engineering and laboratory techniques until 2023. As a member of the education team in postgraduate doctoral studies, he has mentored countless students, helping shape the next generation of biochemists and medical professionals.

Kotaška’s influence extends to his role as a reviewer for several prestigious biomedical journals, such as the Central European Journal of Biology, Open Heart Journal, and Diagnostics. His expertise in statistical methods, including regression analysis, survival analysis, and data evaluation, has positioned him as a thought leader in clinical diagnostics.

📚 Publications and Peer Review

With 66 peer-reviewed publications and 12 book chapters to his name, Kotaška’s work has been widely recognized and cited in the scientific community. His publications span critical topics in clinical biochemistry, genetic research, and molecular diagnostics. His H-index of 10 reflects the significant impact of his research, with 317 citations from scholars and professionals in related fields. His commitment to advancing clinical diagnostics and biochemistry is evident in his body of work, which continues to inform and guide research in these areas.

🏅 Legacy and Future Contributions

Kotaška’s legacy is rooted in his contributions to clinical biochemistry and medical diagnostics. His work on improving diagnostic efficiency, standardizing laboratory procedures, and exploring biomarkers in diseases has set a benchmark in the medical field. As a corresponding member of prominent international organizations, such as the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the International Federation of Clinical Chemistry (IFCC), his influence extends beyond the Czech Republic to the global scientific community.

Karel Kotaška’s future contributions are likely to focus on further enhancing diagnostic tools and treatment methods, particularly in the fields of cardiovascular diseases and cancer research. His ongoing work in investigating the effects of innovative therapeutic treatments for chronic heart failure demonstrates his commitment to improving patient outcomes. Additionally, his leadership in laboratory standardization efforts will continue to shape the practices of clinical laboratories worldwide, ensuring that diagnostics remain accurate, efficient, and globally harmonized.

🌟 Conclusion

Karel Kotaška’s career is a testament to his dedication to advancing medical science and education. His multifaceted contributions as a researcher, educator, and laboratory manager have left a lasting impact on the fields of biochemistry and clinical diagnostics. His work continues to influence both the scientific community and clinical practices, ensuring his legacy as a leading figure in medical chemistry and clinical biochemistry for years to come.

🎓Publication 

Polycyanoacrylate (super glue) as bladder concretion in a patient after bilateral inguinal hernioplasty

  • Authors   : Karel Kotaška; Milan Polák; Antonín Brisuda; Richard Průša
  • Journal    : Annals of Clinical Biochemistry
  • Year         :2020